A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer’s Disease – Madison.com

February 11, 2017 by  
Filed under Alzheimers News

Sponsored By

Madison.com
A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease
Madison.com
Alzheimer's disease is a terrible illness which affects an estimated 5.4 million Americans today. Alzheimer's is also the 6th leading cause of death nationally. Unfortunately, there are currently only two types of FDA-approved drugs (memantine and …

and more »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*